These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 19707956)
1. Are masking abnormalities in schizophrenia specific to type-B masking? Skottun BC; Skoyles JR World J Biol Psychiatry; 2009; 10(4 Pt 3):798-808. PubMed ID: 19707956 [TBL] [Abstract][Full Text] [Related]
2. Are masking abnormalities in schizophrenia limited to backward masking? Skottun BC; Skoyles JR Int J Neurosci; 2009; 119(1):88-104. PubMed ID: 19116834 [TBL] [Abstract][Full Text] [Related]
3. Stereopsis and magnocellular sensitivity in schizophrenia. Skottun BC; Skoyles JR World J Biol Psychiatry; 2009; 10(4 Pt 3):697-701. PubMed ID: 18609415 [TBL] [Abstract][Full Text] [Related]
4. Anomalous visual experiences, negative symptoms, perceptual organization and the magnocellular pathway in schizophrenia: a shared construct? Kéri S; Kiss I; Kelemen O; Benedek G; Janka Z Psychol Med; 2005 Oct; 35(10):1445-55. PubMed ID: 16164768 [TBL] [Abstract][Full Text] [Related]
5. Vernier threshold in patients with schizophrenia and in their unaffected siblings. Kéri S; Kelemen O; Benedek G; Janka Z Neuropsychology; 2004 Jul; 18(3):537-42. PubMed ID: 15291731 [TBL] [Abstract][Full Text] [Related]
7. Visual backward-masking deficits in schizophrenia: relationship to visual pathway function and symptomatology. Butler PD; DeSanti LA; Maddox J; Harkavy-Friedman JM; Amador XF; Goetz RR; Javitt DC; Gorman JM Schizophr Res; 2003 Feb; 59(2-3):199-209. PubMed ID: 12414076 [TBL] [Abstract][Full Text] [Related]
8. A role for the 'magnocellular advantage' in visual impairments in neurodevelopmental and psychiatric disorders. Laycock R; Crewther SG; Crewther DP Neurosci Biobehav Rev; 2007; 31(3):363-76. PubMed ID: 17141311 [TBL] [Abstract][Full Text] [Related]
9. A few remarks on attention and magnocellular deficits in schizophrenia. Skottun BC; Skoyles JR Neurosci Biobehav Rev; 2008; 32(1):118-22. PubMed ID: 17651801 [TBL] [Abstract][Full Text] [Related]
14. Contrast sensitivity and magnocellular functioning in schizophrenia. Skottun BC; Skoyles JR Vision Res; 2007 Oct; 47(23):2923-33. PubMed ID: 17825350 [TBL] [Abstract][Full Text] [Related]
15. Impairment in visual and spatial perception in schizophrenia and delusional disorder. Hardoy MC; Carta MG; Catena M; Hardoy MJ; Cadeddu M; Dell'Osso L; Hugdahl K; Carpiniello B Psychiatry Res; 2004 Jun; 127(1-2):163-6. PubMed ID: 15261715 [TBL] [Abstract][Full Text] [Related]
16. Paracontrast and metacontrast in schizophrenia: clarifying the mechanism for visual masking deficits. Rassovsky Y; Green MF; Nuechterlein KH; Breitmeyer B; Mintz J Schizophr Res; 2004 Dec; 71(2-3):485-92. PubMed ID: 15474919 [TBL] [Abstract][Full Text] [Related]
17. Pseudoneglect in schizophrenia: a line bisection study with cueing. Michel C; Cavezian C; d'Amato T; Dalery J; Rode G; Saoud M; Rossetti Y Cogn Neuropsychiatry; 2007 May; 12(3):222-34. PubMed ID: 17453903 [TBL] [Abstract][Full Text] [Related]
19. Regional brain activity associated with visual backward masking. Green MF; Glahn D; Engel SA; Nuechterlein KH; Sabb F; Strojwas M; Cohen MS J Cogn Neurosci; 2005 Jan; 17(1):13-23. PubMed ID: 15701236 [TBL] [Abstract][Full Text] [Related]
20. Backward and forward visual masking in schizophrenia and its relation to global motion and global form perception. Brittain PJ; Surguladze S; McKendrick AM; Ffytche DH Schizophr Res; 2010 Dec; 124(1-3):134-41. PubMed ID: 20685082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]